Jens Hillengass, MD, University Hospital Heidelberg, Heidelberg, Germany discusses imaging in multiple myeloma (MM). He explores current techniques and weighs up the pros and cons of each, including diffusion-weighted imaging (DWI). Recorded at the 2017 European Multiple Myeloma Academy (EMMA) in Vienna, Austria.
This program was sponsored by Celgene through an unrestricted educational grant to Video Journal of Hematological Oncology.

свернуть